Emfo LLC boosted its position in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 3.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,534 shares of the company’s stock after buying an additional 350 shares during the period. Procter & Gamble accounts for approximately 1.4% of Emfo LLC’s portfolio, making the stock its 22nd biggest holding. Emfo LLC’s holdings in Procter & Gamble were worth $1,544,000 at the end of the most recent quarter.
Several other institutional investors also recently added to or reduced their stakes in the company. Wyrmwood Management LLC acquired a new position in shares of Procter & Gamble in the fourth quarter valued at approximately $29,000. Mendota Financial Group LLC increased its holdings in shares of Procter & Gamble by 636.6% in the fourth quarter. Mendota Financial Group LLC now owns 302 shares of the company’s stock valued at $44,000 after purchasing an additional 261 shares during the period. Itau Unibanco Holding S.A. acquired a new position in shares of Procter & Gamble in the second quarter valued at approximately $50,000. Morton Brown Family Wealth LLC increased its holdings in shares of Procter & Gamble by 206.6% in the fourth quarter. Morton Brown Family Wealth LLC now owns 417 shares of the company’s stock valued at $61,000 after purchasing an additional 281 shares during the period. Finally, Activest Wealth Management increased its holdings in shares of Procter & Gamble by 49.7% in the fourth quarter. Activest Wealth Management now owns 455 shares of the company’s stock valued at $67,000 after purchasing an additional 151 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Trading Up 0.1 %
Procter & Gamble stock traded up $0.12 during trading on Monday, hitting $155.45. The company’s stock had a trading volume of 5,753,652 shares, compared to its average volume of 6,864,547. The stock has a market capitalization of $365.78 billion, a price-to-earnings ratio of 26.22, a P/E/G ratio of 3.18 and a beta of 0.44. The stock’s fifty day moving average is $159.32 and its 200 day moving average is $152.63. The Procter & Gamble Company has a 1-year low of $141.45 and a 1-year high of $163.14. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.44 and a current ratio of 0.64.
Procter & Gamble Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be paid a dividend of $1.0065 per share. The ex-dividend date of this dividend is Thursday, April 18th. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 annualized dividend and a yield of 2.59%. Procter & Gamble’s dividend payout ratio is currently 62.98%.
Analysts Set New Price Targets
A number of analysts recently weighed in on PG shares. Truist Financial upgraded Procter & Gamble from a “hold” rating to a “buy” rating and lifted their price target for the company from $160.00 to $175.00 in a research note on Monday, March 11th. Barclays lifted their price target on Procter & Gamble from $165.00 to $168.00 and gave the company an “overweight” rating in a research note on Friday. Raymond James boosted their target price on Procter & Gamble from $170.00 to $175.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 24th. Wells Fargo & Company boosted their target price on Procter & Gamble from $162.00 to $170.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 24th. Finally, The Goldman Sachs Group initiated coverage on Procter & Gamble in a research report on Friday, March 1st. They set a “neutral” rating and a $168.00 target price on the stock. Seven equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $168.53.
Check Out Our Latest Stock Report on Procter & Gamble
Insiders Place Their Bets
In other news, CEO Gary A. Coombe sold 22,000 shares of the company’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $161.32, for a total value of $3,549,040.00. Following the completion of the sale, the chief executive officer now owns 36,845 shares of the company’s stock, valued at $5,943,835.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 74,443 shares of the stock in a transaction that occurred on Wednesday, January 24th. The stock was sold at an average price of $153.30, for a total transaction of $11,412,111.90. Following the transaction, the chief executive officer now owns 973 shares of the company’s stock, valued at approximately $149,160.90. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Gary A. Coombe sold 22,000 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $161.32, for a total value of $3,549,040.00. Following the sale, the chief executive officer now owns 36,845 shares in the company, valued at $5,943,835.40. The disclosure for this sale can be found here. Insiders sold 279,063 shares of company stock worth $43,187,745 over the last three months. 0.17% of the stock is owned by insiders.
Procter & Gamble Company Profile
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
Read More
- Five stocks we like better than Procter & Gamble
- What Does Downgrade Mean in Investing?
- The Charles Schwab Company Can Hit New Highs
- 3 Warren Buffett Stocks to Buy Now
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- Best Stocks Under $5.00
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.